Cargando…
Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy
At the end of 2019, an emerging outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first reported from Wuhan, China. The first manifestations of patients infected with SARS-CoV-2 was flu-like symptoms, while other type of manifestations, especially gastrointestinal...
Autores principales: | Nejadghaderi, Seyed Aria, Nazemalhosseini-Mojarad, Ehsan, Asadzadeh Aghdaei, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774521/ https://www.ncbi.nlm.nih.gov/pubmed/33482620 http://dx.doi.org/10.1016/j.mehy.2020.110476 |
Ejemplares similares
-
Gut microbiota, epigenetic modification and colorectal cancer
por: Rezasoltani, Sama, et al.
Publicado: (2017) -
Expression and Clinical Significance of Novel Long Noncoding
RNA Fibroblast Growth Factor 10AS and FGF10 in
Colorectal Cancer
por: Rejali, Leili, et al.
Publicado: (2021) -
Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer
por: Savabkar, Sanaz, et al.
Publicado: (2013) -
The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013) -
Coexistence of KRAS and BRAF Mutations in Colorectal
Cancer: A Case Report Supporting The Concept of
Tumoral Heterogeneity
por: Larki, Pegah, et al.
Publicado: (2017)